Ignite Creation Date:
2024-05-06 @ 5:17 PM
Last Modification Date:
2024-10-26 @ 2:25 PM
Study NCT ID:
NCT05253053
Status:
RECRUITING
Last Update Posted:
2024-01-03
First Post:
2022-01-26
Brief Title:
To Evaluate Efficacy and Safety of TT-00420 Tinengotinib as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
Sponsor:
TransThera Sciences Nanjing Inc
Organization:
TransThera Sciences Nanjing Inc
Organization Data
Organization:
TransThera Sciences Nanjing Inc
Class:
INDUSTRY
Study ID:
TT00420CN04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
TransThera Sciences Nanjing Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None